CHI3L1 and head and neck cancer: Plasma YKL-40 is elevated, defined as higher than the age-adjusted 95th percentile of plasma YKL-40 in healthy subjects, in 53% of patients with head and neck cancer [69] and increased with stage in patients with cervix squamous cell carcinoma [66,67], Figure 4.